Abbott LaboratoriesABTNYSE
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+0.5%
5Y CAGR+5.1%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+0.5%/yr
vs +9.3%/yr prior
5Y CAGR
+5.1%/yr
Recent deceleration
Acceleration
-8.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$44.33B+5.7%
2024$41.95B+4.6%
2023$40.11B-8.1%
2022$43.65B+1.3%
2021$43.08B+24.5%
2020$34.61B+8.5%
2019$31.90B+4.3%
2018$30.58B+11.6%
2017$27.39B+31.3%
2016$20.85B-